Hormonal

Glucagon

Also known as: GlucaGen, Baqsimi

FDA Approved
Share:

Key Facts: Glucagon

Category
Hormonal
FDA Status
FDA Approved
Clinical Status
FDA Approved - Hypoglycemia and diagnostic
Administration
Injection, intranasal, or auto-injector
Typical Dose
Limited community data available
Frequency
See research protocols
Duration
Single dose emergency use
Also Known As
GlucaGen, Baqsimi

Mechanism of Action

Glucagon binds to glucagon receptors in the liver, activating glycogenolysis and gluconeogenesis to raise blood glucose. Also relaxes smooth muscle in the GI tract for diagnostic imaging.

Research Summary

Life-saving treatment for severe hypoglycemia since the 1960s. Newer formulations include nasal spray (Baqsimi) and stable liquid (Gvoke). Essential emergency medication for insulin users.

Trial Progress:FDA Approved
Pre
I
II
III
IV
FDA

Dosing Information

FDA Approved·Human clinical trials completed, FDA approved

Typical Dosing

Community experience

Common Dose

Limited community data available

Range

See research dosing

Frequency

See research protocols

Research Dosing

Scientific studies

Emergency dosing

Doses from Studies

Duration

Single dose emergency use

Administration

Injection, intranasal, or auto-injector

Timing & Administration

Best Time to Take

Morning

Follow specific protocol

Food Recommendation

Take on empty stomach

Why This Timing?

Metabolic peptides often work best when taken in the morning to support daytime energy expenditure.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • Nausea (up to 35%)
  • Vomiting
  • Headache
  • Hypertension
  • Tachycardia
  • Allergic reactions
  • Rebound hypoglycemia
  • CONTRAINDICATED with pheochromocytoma
  • FDA approved

References

Research This Peptide Further

Frequently Asked Questions

What does Glucagon do?

A counter-regulatory hormone to insulin. FDA approved for severe hypoglycemia treatment and diagnostic procedures.

How does Glucagon work?

Glucagon binds to glucagon receptors in the liver, activating glycogenolysis and gluconeogenesis to raise blood glucose. Also relaxes smooth muscle in the GI tract for diagnostic imaging.

Is Glucagon FDA approved?

Yes, Glucagon is FDA approved. FDA Approved - Hypoglycemia and diagnostic

What are the side effects of Glucagon?

Reported side effects include: Nausea (up to 35%), Vomiting, Headache, Hypertension, Tachycardia. Individual responses vary based on dosage, duration, and personal health factors.

What is the typical dose of Glucagon?

Community-reported common dose: Limited community data available (See research protocols). Range: See research dosing. Administration: Injection, intranasal, or auto-injector. Community-reported doses. Not medical advice. Consult healthcare provider.

Related Peptides

Peptides commonly compared with Glucagon or used in similar applications.

Want updates on Glucagon research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.